The Infectious disease Grand Rounds
Sabrina Assoumou, MD, MPH & Andrew Henderson, PhD
“ Newer Antibiotics”
Helen Boucher, MD
Tufts University Medical School
Thursday, March 30th, 2017
12:00 noon – 1:00 pm
Location: Evans Seminar Room (112A)
Target Audience: Adult and Pediatric HIV clinic medical staff; ID fellows; house staff; HIV clinic nursing, social work, pharmacists, and research staff; other MDs/PhDs in the Section of Infectious Diseases and the BUSPH with an interest in HIV/AIDS; health care providers in the community.
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Boston University School of Medicine designates this live activity for 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
Pharmaceutical Policy Research Seminar (PPRS) – FDA Regulation, Innovation, and the 21st Century Cures Act
Pharmaceutical Policy Research Seminar (PPRS)
DPM, Inui Conference Room Directions
Landmark Center, 401 Park Drive, Suite 401 East, Boston, MA 02215 OR you may join the BU Pharm Program at 801 Massachusetts Avenue, Boston, MA in room CT374 where we will be live streaming the seminar
September 28, 2016
noon – 1:00 pm
Aaron S. Kesselheim, M.D., J.D., M.P.H.
Associate Professor of Medicine at Harvard Medical School
Director, Program On Regulation, Therapeutics, And Law (PORTAL)
Division of Pharmacoepidemiology and Pharmacoeconomics
Brigham and Women’s Hospital
“FDA Regulation, Innovation, and the 21st Century Cures Act”
In 2015, the House of Representatives passed the 21st Century Cures Act to promote approval of innovative drugs, and this year the Senate has provided preliminary approval to certain provisions in it. We will review some of the proposals in the bill and evidence about their possible impact.
Databases available for pediatric post-marketing pharmacoepidemiology: which databases for which questions?
Topic: Databases available for pediatric post-marketing pharmacoepidemiology: which databases for which questions?
Speaker – Ann W. McMahon, M.D., M.S., Supervisory Medical Officer, Deputy Director of Science and Director of KidNet, Office of Pediatric Therapeutics in the Office of the Commissioner, U.S. Food & Drug Administration
When: Monday, October 17, 12:00-1:00pm at 1010 Commonwealth Avenue, Boston, MA
MassBio is pleased to announce the 3rd Annual Patient Advocacy Summit to be held Wednesday, September 28, 2016.
This event brings industry leaders together with patient advocates and other stakeholders to examine ways in which life sciences companies can more fully incorporate the patient voice into the work they do— not just approaching regulatory applications or at commercialization, but throughout the drug development cycle.
The day-long event will include panel discussions, case study presentations (spotlighting industry/patient partnerships), a keynote address, and awards ceremony, as well as a networking breakfast, lunch and cocktail reception. Expected attendance is 180 patient advocacy professionals, patient organizations and other stakeholders.
Review the agenda and register for the event here.
Quintiles is hosting an advisory services information session on Tuesday, October 4 from 5-5:50pm in R103. For more information review the flyer.
Access to Novel, Highly-Priced Cancer Medicines in Low-Resource Settings – Ethical Challenges on the Path to Universal Health Coverage Webinar
The Drug Policy Research Group at the Department of Population Medicine at Harvard Medical School and Harvard Pilgrim Health Care Institute together with experts from the National University of Singapore and Health System Global are pleased to invite you to the webinar “Access to Novel, Highly-Priced Cancer Medicines in Low-Resource Settings – Ethical Challenges on the Path to Universal Health Coverage”.
The webinar will take place on Wednesday 12th of October from 8:00-9:00am EDT.
Please visit Health Systems Global website to find the webinar announcement text and the registration link.
In case you have any questions please do not hesitate to contact Christine Leopold at firstname.lastname@example.org.
Deloitte Advisory’s Life Sciences and Health Care Division Networking and Info Session – Apply to Attend
Deloitte Advisory’s Life Sciences and Health Care Division is hosting a Networking and Info Session in their Boston office on Sept. 22nd at 6pm.
Students must APPLY to be “selected” to attend. Details on how to apply are located here. This is also posted in Handshake. Note: Students will be notified by Sept. 16th if they are selected. There is no deadline, but interested applicants should apply as soon as possible.
The Questrom School of Business would like to invite you to the Fourth Annual Health and Life Sciences Conference at Boston University. Tickets are now on sale at a discounted rate until Friday September 9th. Please see the flyer for more information regarding the conference and to purchase tickets.
Access to Essential Medicines as a Key Determinant to Universal Health Coverage
Thursday, September 15, 2016
What is the role of pharmaceuticals in a prevention and public health agenda? The symposium will explore this question by engaging public and private sector actors.
The free, self-paced version of the online Course on Medicines in Health Systems Working Toward Universal Health Coverage is available at the World Bank Open Learning Campus (OLC).
For a description of the course and to enroll, please see here:https://olc.worldbank.org/content/medicines-health-systems-working-toward-universal-health-coverage-self-paced
For the user guide to OLC self-paced courses, please see here:https://docs.google.com/presentation/d/16DvQGQeCylfUeyNBiSCW7uWnfqhO9KZ4KlFEPI3-9fc/edit#slide=id.p4